Grifols | GRFS - Capital De Empréstimo

Preço das Ações
8.39
Mudança Diária
0.18 2.19%
Mensal
4.22%
Anual
19.86%
Q2 Previsão
7.99




Capital De Empréstimo Alterar Data
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
aTyr Pharma USD 12.51M 12.11M 2025-12
Bio Path USD 0 0 2025-03
Brainstorm Cell Therapeutics USD 0 0 2025-03
Capricor Therapeutics USD 3.38M 0 2025-03
Cara Therapeutics USD 0 0 2025-03
Esperion Therapeutics USD 457.65M 9.5M 2025-12
GlaxoSmithKline GBP 14.71B 186M 2025-12
Grifols EUR 9.95B 722.93M 2025-12
Immunic USD 0 0 2024-06
Infinity Pharmaceuticals USD 0 0 2022-06
Minerva Neurosciences USD 0 86.58M 2024-09
Nektar Therapeutics USD 63.16M 44.35M 2025-12
Sangamo BioSciences USD 0 0 2022-06
TherapeuticsMD USD 0 0 2022-03